Premium
Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1
Author(s) -
Ng Kevin T.P.,
Lee Terence K.W.,
Cheng Qiao,
Wo Jana Y.H.,
Sun Chris K.W.,
Guo DongYong,
Lim Zophia X.,
Lo ChungMau,
Poon Ronnie T.P.,
Fan SheungTat,
Man Kwan
Publication year - 2010
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.25105
Subject(s) - small hairpin rna , cancer research , carcinogenesis , metastasis , downregulation and upregulation , rna interference , cell growth , biology , hepatocellular carcinoma , cell culture , gene , cancer , gene knockdown , rna , genetics
We previously demonstrated that the overexpression of homeoprotein Six1 in hepatocellular carcinoma (HCC) patients is associated with venous infiltration, advanced pathologic tumor metastasis (pTNM) stage and poor overall survival rate (Ng et al. Br J Cancer 2006;95:1050–5). In this study, short hairpin RNA (shRNA) interference approach was used to suppress the expression of Six1 in a metastatic HCC cell line MHCC97L. Stable transfectant MHCC97L‐shSix1 carrying Six1‐specific shRNA plasmid was established to downregulate Six1 expression to about 40% when compared with MHCC97L‐Control. In vitro functional assays demonstrated that the growth rate and proliferation ability of MHCC97L‐shSix1 cells were markedly decreased. Moreover, significant decrease of cell motility and invasiveness were observed in MHCC97L‐shSix1 cells. Data from in vivo xenograft tumorigenesis model demonstrated that the size of tumor in MHCC97L‐shSix1 group was dramatically reduced. Experimental and spontaneous metastasis models indicated that targeting Six1 suppression noticeably reduced the pulmonary metastasis in MHCC97L‐shSix1 group. To identify Six1‐regulated targets, cDNA microarray was employed to compare the expression profiles of MHCC97L‐Control and MHCC97L‐shSix1 cells. Twenty‐eight downregulated and 24 upregulated genes with known functions were identified in MHCC97L‐shSix1. The functions of these target genes are involved in diverse biological activities. Our data suggest that Six1 may be involved in regulation of proliferation and invasiveness of HCC; thus targeting suppression of Six1 is a viable option for treating HCC patients.